Automated simultaneous triple dissolution profiles of two drugs, sulphamethoxazole-trimethoprim and hydrochlorothiazide-captopril in solid oral dosage forms by a multicommutation flow-assembly and derivative spectrophotometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 36, Issue 3, 2004, Pages 549-557

  Tomsu D ^a   Catala Icardo M ^a   Martinez Calatayud J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Captopril; Dissolution profiles; Hydrochlorothiazide; In vitro availability; Multicommutation; Pharmaceuticals; Solenoid valves; Sulphamethoxazole; Trimethoprim

Indexed keywords

BRONQUI MUCIL; CAPTOPRIL; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; COTRIMOXAZOLE; ECADIU; EDUPRIM; HYDROCHLOROTHIAZIDE; MOMENTOL; NORMON; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACCURACY; ANALYTIC METHOD; ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG SOLUBILITY; MULTICOMMUTATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY;

ADMINISTRATION, ORAL; CAPTOPRIL; DOSAGE FORMS; HYDROCHLOROTHIAZIDE; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 7444257909     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2004.07.009     Document Type: Article

References (27)

1. CPMP, Committee for proprietary Medicinal Products, Note on guidance on the Investigation of bioavailability and bioequivalence, The European Agency for the Evaluation of Medicinal products, 1998.
2. FDA, Food and Drug Administration, Guidance for Industry, Dissolution testing of immediate release solid dosage oral forms, US Department of Health and Human Services, Centre for drug Evaluation and Research, Washington, 1997.
3. United States Pharmacopoeia (USPXXII) (National Formulary), pp. 1578-1579.
4. British Pharmacopoeia, Her Majesty's Stationary Office, London, 1993, pp. 547-586.
5. Real Farmacopea Española, Ministerio de Sanidad y Consumo, Madrid, 1997, pp. 1601-1720.
6. M. Koupparis, P. Macheras, and L. Tsaprounis Int. J. Pharm. 27 1985 349 359
7. J. Martínez Calatayud Flow Injection Analysis of Pharmaceuticals: Automation in the Laboratory 1996 Taylor and Francis London, UK pp. 137-140
8. J.L. López Paz, and J. Martínez Calatayud Pharm. Technol. Eur. 10 1998 16 22
9. G.A. Rivas, S. Laredo Ortiz, and J. Martínez Calatayud Anal. Lett. 29 1996 2115 2124
10. A. Moreno Galvez, J.V. García Mateo, and J. Martínez Calatayud J. Pharm. Biomed. Anal. 27 2002 1027 1036
11. A. Moreno Gálvez, J.V. García Mateo, and J. Martínez Calatayud J. Pharm. Biomed. Anal. 30 2002 535 545
12. L. Lahuerta Zamora, J. Martínez Calatayud, A. Danet, and M. Cheregi Roum. Chem. Q Rev. 3 1995 51 56
13. P. Solich, C.K. Polydorou, M.A. Koupparis, and C.A. Efstathiou Biomed. Chromatogr. 13 1999 113 116
14. E. Vranic, M. Catalá Icardo, and J. Martínez Calatayud J. Pharm. Biomed. Anal. 33 2003 1039 1048
15. M. Catalá-Icardo, J.V. García-Mateo, and J. Martínez Calatayud Trends Anal. Chem. 21 2002 366 378
16. http://www.uv.es/∼martinej/Flow-Analysis/.
17. R.P.R. Rocha, B.F. Reis, E.A.G. Zagatto, J.L.F.C. Lima, R.A.S. Lapa, and J.L.M. Santos Anal. Chim. Acta 468 2002 119 131
18. R.D. Bautista, F. Jiménez, A.I. Jiménez, and J.J. Arias Talanta 40 1993 1687 1694
19. J.J. Berzas Nevado, J. Rodriguez Flores, G. Guiberteau Cabanillas, and M.J. Vilaseńor Llerena Talanta 45 1998 942 993
20. S. Görög Ultraviolet-Visible Spectrophotometry in Pharmaceutical Analysis 1995 CRC Press Boca Ratón, FL, USA pp. 115-122
21. Analytical Profiles of Drug Substances, vol. 7 1978 Academic Press Orlando, FL, USA
22. A. Gringauz Introduction to Medicinal Chemistry. How Drugs Act and Why 1997 Wiley-VCH pp. 467-469
23. Analytical Profiles of Drug Substances, vol. 11 1978 Academic Press New York, USA pp. 80-129
24. S.L. Morgan, and S.N. Deming Anal. Chem. 46 1974 1170 1173
25. J.A. Nelder, and R. Mead Computer 7 1965 308 310
26. Program "Statistica", working in Windows, Copyright Statsoft Inc., 1993.
27. J. Swanbrick J.C. Boylai Encyclopaedia of Pharmaceutical Technology 1992 Marcel Dekker Inc. New York 121 167